Diabetic Nephrology

Diabetic Diabetic nephropathy (DN) is typically defined by macro albuminuria—that is, a urinary albumin excretion of more than 300 mg in a 24-hour collection—or macro albuminuria and abnormal renal function as represented by an abnormality in serum creatinine, calculated creatinine clearance, or glomerular filteration filtration rate (GFR). Clinically, diabetic nephropathy is characterized by a progressive increase in proteinuria and decline in GFR, hypertension, and a high risk of cardiovascular morbidity and mortality. Diabetic nephropathy is a clinical syndrome characterized by the following: Proteinuria was first recognized in diabetes mellitus in the late 18th century.

  • Diabetic Microvascular Complications, Diabetic Nephropathy
  • Nephropathology and pathogenesis of diabetic nephropathy
  • Contrast nephropathy, uric acid nephropathy
  • Diabetic glomerulosclerosis, IgA nephropathy
  • HIV associated nephropathy
  • Glycemic control, diabetic ketoacidosis

Related Conference of Diabetic Nephrology

December 04-05 2017

17th Annual Conference on Nephrology

Dallas, Texas, USA
May 14-15, 2018

19th Global Nephrologists Annual Meeting

Rome, Italy
June 8-9, 2018

3rd Annual Kidney Congress

Baltimore, USA
June 8-9, 2018

16th Annual Dialysis & Renal Medicine Conference

Baltimore, USA
June 20-22, 2018

World Nephrology Congress

Paris, France
June 28-29, 2018

20th World Kidney Congress

Berlin, Germany
July 23-24, 2018

15th World Nephrologists Meeting

Kuala Lumpur, Malaysia
August 20-21, 2018

Annual Conference on Nephrology & Urology

Chicago, USA
July 23-24, 2018

14th World Nephrology conference

Melbourne, Australia
October 15-16, 2018

22nd European Nephrology Conference

Warsaw, Poland

Diabetic Nephrology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in